BACKGROUND: C-reactive protein (CRP), a sensitive marker of the acute-phase response, has been associated with future cardiovascular endpoints independently of other risk factors. A joint analysis of the role of risk factors in predicting mean concentrations and variation of high-sensitivity CRP (hs-CRP) in serum has not been carried out previously.
METHODS:
We used data from 1003 myocardial infarction (MI) survivors who had hs-CRP measured monthly up to 8 times and multivariate mixed effects statistical models to study the role of time-variant and -invariant factors on the geometric mean of and the intraindividual variation in hs-CRP concentrations.
RESULTS:
Patients with Ն6.5% glycosylated hemoglobin (HbA1c) had 26.2% higher hs-CRP concentrations (95% CI, 7.2%-48.6%) and 20.7% greater variation in hs-CRP values (P ϭ 0.0034) than patients with typical baseline HbA1c values (Ͻ6.5%). Similar but less pronounced differences were seen in patients with a selfreported diagnosis of type 2 diabetes. hs-CRP concentrations showed less variation in patients who reported angina pectoris, congestive heart failure, or emphysema (Ϫ11.0%, Ϫ24.9%, and Ϫ41.6%, respectively, vs patients without these conditions) but greater variation in males and smokers (ϩ24.8% and ϩ27.3%, respectively, vs females and nonsmokers). Exposures in the 24 h before blood sampling, including environmental exposure to tobacco smoke, alcohol consumption, and extreme stress, did not have a major impact.
CONCLUSIONS:
One or 2 hs-CRP measurements may not be sufficient to adequately characterize different patient groups after MI with similar precisions. We found hs-CRP concentrations to be especially variable in males, smokers, and patients with increased HbA1c values.
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C-reactive protein (CRP), 14 a sensitive marker of the acute-phase response, has attracted increasing attention in recent years because many epidemiologic studies have shown consistent positive associations between high-sensitivity CRP (hs-CRP) concentrations in the peripheral circulation and the risk of future cardiovascular events, independently of established risk factors. Associations have been found with angina pectoris (1 ) and "hard" coronary and cerebrovascular events in men and women (2 ) . Koenig et al. (3 ) reported an almost 3-fold increase in the risk of a first major coronary event for individuals in the highest quintile of the hs-CRP distribution in a random sample of initially healthy men from the general population. These findings have led to an ongoing discussion on whether hs-CRP should be measured routinely in individuals at risk of cardiovascular disease (4 ) . The CDC and the American Heart Association recently recommended that hs-CRP be measured in individuals at intermediate risk (as defined by the Framingham Risk Score), with the assays to be performed on 2 samples from each person, fasting or nonfasting, taken approximately 2 weeks apart. In the case of an hs-CRP measurement Ͼ10 mg/L, indicating an acute inflammatory process, the measurement should be discarded and repeated 2 weeks later (5 ) . For routine screening, knowledge of basic determinants of hs-CRP concentrations is essential. Several determinants have been studied intensively in the past, including nutrition (6 ), medication (2, (7) (8) (9) (10) , smoking (11, 12 ) , body mass index (BMI), and physical activity (13) (14) (15) ; however, most of these studies relied on only 1 or 2 measurements per patient. Only a few studies have examined factors acutely affecting hs-CRP concentrations (13, 14, 16 ) or the degree of within-patient variation in hs-CRP concentration. We used data from a large European study of myocardial infarction (MI) survivors who had hs-CRP measured up to 8 times in an attempt to conduct, for the first time, a joint analysis of the role of risk factors in predicting the mean hs-CRP concentration and the intraindividual variation in hs-CRP. Given that clinical practice may consider preventive measures based on a single hs-CRP measurement, this study may contribute important additional information.
Materials and Methods

STUDY POPULATION
The AIRGENE study, a prospective longitudinal study of post-MI patients, was performed in 6 European cities-Athens (Greece), Augsburg (Germany), Barcelona (Spain), Helsinki (Finland), Rome (Italy), and Stockholm (Sweden). Candidates for the study were identified from population registries of MI patients (Augsburg, KORA-Cooperative Health Research in the Augsburg Region (17 ); Barcelona; Stockholm) or from administrative databases of hospital admissions (Athens, Helsinki, Rome). MI was defined according to the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction (18 ) ; the study design has been described in detail elsewhere (19 ) . In brief, the study recruited patients 35-80 years of age who had experienced an MI between 4 months and 6 years before the start of the study. Patients who had undergone interventional procedures Ͻ3 months before the beginning of the study or who had chronic inflammatory diseases were not included. Because AIRGENE initially was a study of the health effects of air pollution, the recruitment of current nonsmokers was preferred, but the inclusion of smokers in some of the centers was unavoidable. All study partners had the study protocol approved by their local human-studies committees, and written informed consent was obtained from all patients. All methods used in the study centers were conducted according to common standard operating procedures.
CLINICAL MEASUREMENTS
Patients were invited to participate in 6 to 8 clinical visits at approximately monthly intervals between May 2003 and July 2004. At the first visit, the patient completed a baseline questionnaire regarding comorbidities, regular exercise, smoking history, exposure to environmental tobacco smoke (ETS), socioeconomic status, and alcohol intake. Data recorded regarding medication intake included brand names, doses, and intake pattern. Clinical measurements included blood pressure and BMI, and a serum sample was taken to assess baseline serum lipids, glycosylated hemoglobin (HbA1c) (an indicator of glucose control), and Nterminal pro-B-type natriuretic peptide (a marker of hemodynamic stress).
Each clinical visit was scheduled at the same time of the day and on the same day of the week to minimize the impact of circadian and weekly variation. If patients had acute infections such as a cold or influenza during the 3 days preceding the scheduled visit, examinations were postponed or the blood samples were excluded from analyses.
The patient was asked to recall medication intake for the previous 7 days at each clinical visit and to complete a short questionnaire about time-varying variables in the previous 24 h, such as active and passive smoking, physical activity, perception of extreme stress or anger, consumption of alcohol and black or green tea, and the time of the latest meal before blood draw.
Venous blood samples for preparing EDTAplasma for hs-CRP measurement were drawn while the patient was sitting. Samples were cooled and stored at 4°C for further processing within a maximum of 4 hours. EDTA-containing blood was centrifuged for 20 min at 2500g in a centrifuge precooled to 4°C. Plasma aliquots were shipped on dry ice to the central laboratory in Ulm, Germany, and were stored at Ϫ80°C until analysis. Blood samples were analyzed for hs-CRP by latex-enhanced immunonephelometry on a BNII analyzer (Siemens). The interassay CVs for hs-CRP were 4.3%, 6.2% and 4.5% at hs-CRP concentrations of 1.17 mg/L, 2.38 mg/L, and 13.5 mg/L, respectively.
STATISTICAL ANALYSES
All statistical analyses were performed with the Statistical Analysis System (SAS) software package (Version 9.1 for Windows; SAS Institute).
We calculated hs-CRP CVs as described by Bland and Altman (20 ) and Fraser and Harris (21 ) . We used the SAS MIXED procedure to compute estimates of between-and within-individual variances, assuming nested normal random-effects models. These compo-nents of variation were then transformed into corresponding CVs, which were calculated as the square root of the respective variance-component estimates divided by the overall mean and then expressed as percentages.
Determinants of mean hs-CRP concentrations. hs-CRP data required log-transformation to fulfill the model assumption of residual normality; therefore, concentration results are given as the geometric mean. To estimate the effect of various determinants on the geometric means of hs-CRP concentrations, we used mixed-effects models with random patient effects accounting for repeated measures. Because the half-life of hs-CRP is 19 h (22 ) and therefore much shorter than the intervals between visits, we assumed a compound symmetry structure for the covariance matrix to model the correlation between repeated measures in each patient. Penalized splines (P-splines) in the additive mixed-model framework allowed for nonparametric exposure-response functions (23 ) .
We first built a confounder model (base model), which included preselected time-invariant patient characteristics, to permit the assumption of a normally distributed random patient intercept. We tested a wide range of variables known from the literature to have a possible influence on hs-CRP, such as city, age, sex, and BMI. Linear variables were added linearly to the model. The decision on whether a specific factor remained in the model was based on the goodness-of-fit according to Akaike's information criterion.
In a second step, additional time-invariant variables not initially considered for the base model (such as reported diseases, regular medication intake, and smoking history) as well as time-varying variables, such as physical activity or alcohol consumption in the 24 h before the blood draw, were added to the base model, always one at a time. To avoid overcontrol, we removed pack-years of smoking from the base model when we analyzed smoking status, and we removed HbA1c for the analysis of diabetes. Variables that described a time difference, such as the time of the last meal before the blood sampling, were categorized into 4 intervals of 6 h each: 0 -5 h, 6 -11 h, 12-17 h, and 18 -23 h before sampling. Results are given as the percent change in the geometric mean of the hs-CRP concentration.
Determinants of hs-CRP variation.
To calculate differences in variation, we used the MIXED procedure in SAS with the "repeated/groupϭ " statement, which calculates the within-patient variation, and a "random/ groupϭ " statement, which allows for different intercepts in the defined groups, representing the betweenpatient variation. A likelihood-ratio test was used to determine if the differences between the groups were statistically significant. Linear variables were categorized beforehand, usually with interquartile ranges. Results are given as variance estimates of log-transformed hs-CRP concentrations, with between-individual and within-individual results presented separately (Fig. 1) , and as the relative difference (in percent) in withinindividual variation compared with the reference group (see tables).
To account for the large number of statistical tests, we corrected the significance level of the P value to 0.00125, which equals a Bonferroni correction for 40 variables.
Sensitivity analyses. We conducted sensitivity analyses for comorbidities that might be associated with the intake of certain medications and used a 2 test to evaluate possible associations between comorbidities and medication intake. If we found an association (P Յ 0.05), we adjusted the multivariable model for the respective medication to investigate whether the comorbidity effect was altered by including medication in the model. Moreover, we calculated a model that included most of the presented variables to identify those variables that led to the greatest increase in variation.
Results
STUDY POPULATION
In total, 1003 patients with at least 2 valid blood samples participated in the study. Of the 6068 collected samples, 255 had to be excluded because of acute infections or surgical procedures that occurred shortly before the clinic visit. Overall, 5813 plasma samples remained for analysis (see Table 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol55/issue2). Table 2 in the online Data Supplement summarizes the patient characteristics by center, and Table 3 in the online Data Supplement presents the patient characteristics according to sex. Mean hs-CRP concentrations were highest in Barcelona and lowest in Helsinki; however, hs-CRP concentrations were not exceptionally high on average. In 75 samples, the hs-CRP concentration was lower than 0.16 mg/L, and these values were set at 0.16 mg/L. More details are given elsewhere (19 ) . The CV was 107% of the overall mean within individuals and 139% between individuals.
ASSOCIATION BETWEEN TIME-INVARIANT VARIABLES AND hs-CRP
Base model. Table 1 shows the associations of patient characteristics with the geometric mean of the hs-CRP concentration and its variation, as estimated jointly from the base model. Male participants had signifi- Variance component values are presented according to patient characteristics (sex, CHF diagnosis, HDL cholesterol concentration, body weight, and chronic bronchitis). cantly lower hs-CRP concentrations than female participants but had greater variation over time in log hs-CRP concentration (Fig. 1) . This difference was less pronounced after controlling for the intake of hormone-replacement medications in women. We found a U-shaped relationship for age with the lowest hs-CRP concentration in the age group of 50 -59 years ( Fig. 2) , whereas most other associations were linear. A separate analysis showed that this effect was mainly driven by the results for men; women had a positive linear association between hs-CRP concentration and age (data not shown). In contrast, hs-CRP variation was greatest in the oldest patient group. Overweight and obese patients (24 ) had higher hs-CRP concentrations than participants with typical weights, but the concentrations in these patients were less variable (Fig. 1) . HbA1c concentrations Ͼ6.5% were positively associated with the geometric mean of and the variation in hs-CRP concentration, whereas a diagnosis of type 2 diabetes was positively associated with the variation but not with the geometric mean ( Table 2) . hs-CRP concentrations were also positively associated with higher concentrations of N-terminal pro-B-type natriuretic peptide and total cholesterol. Tables  2 and 3 summarize the associations of hs-CRP concentration with disease history, lifestyle, and medication intake. A family history of MI was associated with slightly higher hs-CRP concentrations. On the other hand, hs-CRP concentrations showed less variation in patients who reported angina pectoris, congestive heart failure (CHF), emphysema, or a family history of MI (Fig. 1) , and these results remained statistically significant after adjusting for multiple testing. Time since last MI did not show any association with the geometric mean of or the variation in hs-CRP concentration (Table 2). Habitual physical activity did not influence hs-CRP concentrations; however, the variation in hs-CRP concentration seemed to be higher in inactive people and lower in those who were partially active, compared with regularly active study participants. HDL cholesterol was inversely related to the geometric mean of the hs-CRP concentration; greater variation in hs-CRP concentration was noted in patients with increased HDL cholesterol concentrations (Table 3) .
Additional time-invariant variables and hs-CRP.
Patients reporting the intake of statins or other lipid-lowering drugs had lower hs-CRP concentrations and less variation. On the other hand, patients taking angiotensin-converting enzyme inhibitors had greater variation in hs-CRP concentrations, whereas the geometric mean was negatively associated with medication intake (Table 3) . Use of acetylsalicylic acid or Ca 2ϩ -channel blockers did not affect the geometric mean of or the variation in hs-CRP concentration. Table 4 summarizes the results for different smoking-related variables. Twenty-five pack-years of smoking produced an increase of approximately 16% in the geometric mean of the hs-CRP concentration, and inclusion of smoking status in the model had little effect on this result. Including pack-years of smoking, however, removes the borderline effect for ex-smokers that we found in the model that does not include pack-years of smoking. Examination of the effects of smoking and ETS exposure revealed a heterogeneous picture. Current regular smokers and nonsmokers who reported regular ETS exposure had higher hs-CRP concentrations, whereas occasional smokers seemed to have lower hs-CRP concentrations than nonsmokers not regularly exposed to cigarette smoke. The results were not statistically significant, however, especially when pack-years of smoking was included in the model. The numbers of participants were low in several of the groups (Table 4) . 
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ASSOCIATION BETWEEN TIME-VARYING VARIABLES AND hs-CRP
Time-varying variables had either no or a small influence on hs-CRP concentration (Fig. 3A) . Recent alcohol consumption and extreme stress or anger were associated with lower geometric-mean hs-CRP concentrations, but the results were not statistically significant. Whereas physical activity over the previous 24 h showed no association with hs-CRP concentration (Fig. 3A) , physical activity between 6 and 11 hours before blood draw was associated with increased hs-CRP concentrations (Fig. 3B) . For the other time-varying variables, no such time-specific effects were seen. 
SENSITIVITY ANALYSES
Additional adjustment for medication did not change the results for comorbidities (data not shown).
With very few exceptions, the results for the variation model that included all variables at the same time did not differ much from those described in the presented tables. The results revealed the largest increases in hs-CRP variation were for patients with HDL cholesterol concentrations Ͼ0.91 mmol/L, an older age (especially Ͼ70 years), male sex, a log B-type natriuretic peptide concentration of Ն5.98 (ng/L), and intake of antiinflammatory medication (data not shown).
Discussion
We investigated repeated measurements of hs-CRP in a population of MI survivors and found that the variation in hs-CRP concentration within patients over time was only slightly less than the variation between patients. Moreover, our data revealed that certain subgroups had higher geometric-mean hs-CRP concentrations and/or greater variation in the hs-CRP concentration, but higher geometric means and greater variation did not necessarily occur together. Obese and overweight patients and certain age groups had higher hs-CRP concentrations but less variation in concentration. We also found that patients who reported angina pectoris, emphysema, or CHF had less variation in hs-CRP concentration, whereas the geometric-mean concentration did not seem to be affected. On the other hand, for patients with impaired glucose control, as indicated by increased baseline HbA1c concentrations (Ն6.5%), we found a higher hs-CRP concentration and greater hs-CRP variation. We saw similar but less pronounced differences for the diagnosis of type 2 diabetes. Short-term exposures in the 24 h preceding blood draw, such as ETS exposure, alcohol consumption, or extreme stress or anger, did not have a major impact on hs-CRP concentration. This study examined MI patients only, and therefore the results may not be entirely generalizable to a population without cardiovascular disease.
PATIENT CHARACTERISTICS THAT AFFECT hs-CRP CONCENTRATION AND ITS VARIATION
A variety of studies have examined determinants of hs-CRP concentrations. Although some investigators did not report any sex differences (25 ) , others found lower concentrations in men (6, 7, 11, 26 ) , in line with our results. Hutchinson et al. (26 ) hypothesized that the sex difference might be due to estrogen intake in women, and a study of diabetic women has shown significantly higher hs-CRP concentrations in patients receiving hormone-replacement therapy (7 ) . Our data revealed that intake of hormone-replacement medications had a slightly positive but nonsignificant association with hs-CRP concentration (Table 3) , a result that is consistent with this hypothesis.
As for the influence of age on hs-CRP concentrations, some authors have found a positive linear relationship (26 ) , but a lack of an association has also been reported (12 ) . As far as we know, a U-shaped function, as seen in our data, has not previously been reported. This observation could be due to the way the relationships were modeled and/or to the fact that our data were based on MI survivors, whereas most studies have been conducted with participants from the general population.
Consistent with our results, others have reported positive associations of hs-CRP concentration with increased BMI and obesity (12, 15, 25 ) , for smokers compared with nonsmokers (11, 25 ) , and for individuals with low HDL cholesterol concentrations (12, 25 ) . Several studies have shown that statin therapy (9, 10 ) and treatment with angiotensin-converting enzyme inhibitors (27 ) reduce circulating hs-CRP concentrations, results that are in line with our findings. Moreover, hs-CRP-lowering effects have also been seen with acetylsalicylic acid (8 ) . Although our findings were consistent with a small reduction in hs-CRP concentration due to acetylsalicylic acid, these associations were not statistically significant.
To our knowledge, none of the previously published studies examined variation in hs-CRP concentration over time among different subgroups or with respect to possible determinants. Interestingly, we found that an increase of and greater variation in hs-CRP concentration were not necessarily related. Individuals who reported angina pectoris, CHF, or emphysema had less variation in hs-CRP concentration compared with participants who did not report any of these disorders. These findings remained stable for CHF and emphysema, even after adjustment for multiple testing and associated medication intake. Emphysema is often caused by smoking (28 ) , and our data showed that Ͼ80% of the emphysema patients were past or current smokers. Because emphysema and early-stage CHF do not necessarily include an inflammatory component, it is also conceivable that the lower variation in hs-CRP concentration in these patients is merely a marker for a different mechanism, such as an underlying genetic component. Studies of twins have demonstrated a substantial genetic contribution to baseline hs-CRP concentrations (29 ) , and genetic analyses of the AIRGENE data set revealed that minor alleles of several variants of selected candidate genes were significantly associated with intraindividual variation in hs-CRP concentration (30 ) .
Whether different factors affect each other and, if so, how they do remain speculative. It is possible that a combination of variables amplifies hs-CRP variation, although it is also conceivable that certain combinations of factors can reduce such variation. Additionally, factors that are associated with high variation could just be indicators for a different mechanism. For example, the increase in variation associated with medication intake seen in our data might be a direct effect of the medication itself; however, it is more likely that the high variation is due to the underlying disease that led to the prescription of the drug.
RESPONSE TO ENVIRONMENTAL FACTORS
It is still unclear why some patients develop cardiovascular disease or experience an MI due to certain triggers, whereas others do not. Heavy physical exertion (31 ) and extreme anger (32 ) have been reported as causes for an acute MI. In addition, environmental stimuli such as tobacco smoke (33 ) and air pollution (34, 35 ) are associated with an increased risk for adverse cardiovascular events. It is conceivable that individuals with special characteristics react in a more pronounced way to environmental factors than others. A generally higher concentration of inflammation markers, and/or greater variation in inflammation might offer one possible explanation.
We found that patients with increased HbA1c concentrations and patients with self-reported type 2 diabetes have greater variation in hs-CRP concentration, even in this relatively homogeneous population of MI survivors. It is plausible, but quite speculative, that these subgroups also had a stronger reaction (e.g., a more pronounced inflammatory response) to environmental factors. Studies of diabetic patients (7 ) have shown considerably higher mean hs-CRP concentrations than our population, which consisted of only about 20% diabetic individuals. Persistently increased hs-CRP concentrations as well as acute changes in concentrations of inflammation markers have been associated in cohort studies with an increased risk of cardiovascular events (2, 3 ) . This observation might represent a possible link for the reported associations of air pollution and passive smoking with adverse cardiovascular outcomes, because particle-induced systemic inflammation is one of the hypothesized pathways (33, 36 ) . Individuals with certain diseases, such as diabetes and MI, have been demonstrated to have an enhanced susceptibility for air pollution-related conditions, possibly due to a disease-induced increased inflammatory burden (37 ) . We did not see higher hs-CRP concentrations in diabetic patients, but we did observe greater variation in hs-CRP concentration compared with nondiabetic patients. Furthermore, patients with increased HbA1c concentrations (Ն6.5%) had higher hs-CRP concentrations and greater hs-CRP variation. High HbA1c concentrations seem to reflect uncontrolled rather than undiagnosed diabetes, because 89% of the participants with HbA1c values Ͼ6.5% reported a diagnosis of diabetes. On the other hand, only half of the AIRGENE population with diagnosed diabetes met the HbA1c criterion of Ն6.5%. This finding might indicate that metabolically stable diabetic patients are at less risk compared with patients with unstable diabetes.
Our study is in line with others (10 ) in showing a clear negative association between statin intake and hs-CRP concentration. We hypothesize that the intake of statins attenuates the impact of environmental variables, and therefore statin therapy in addition to following recommended guidelines might be beneficial in certain particularly susceptible subgroups to avoid adverse cardiovascular effects of environmental stimuli. More research in this area is clearly needed, however.
SHORT-TERM INFLUENCES ON hs-CRP
Several studies have demonstrated that regular moderate to vigorous exercise leads to a decrease in hs-CRP concentrations, although the results are conflicting and some authors have attributed the detected negative association to a lower BMI in the individuals who exercise rather than to a direct effect of physical activity on inflammation markers (38 ) . Short-term effects, however, have been studied only in individuals whose activities must be considered extreme, even for professional athletes (16 ) . Although our population of MI survivors were expected to perform in only light sporting activities, we found a transient increase in hs-CRP concentration 6 to 11 hours after physical activity that quickly returned to baseline concentrations. A study of postmenopausal women did not observe any increase in hs-CRP concentration at 1 h or 24 h after exercise, compared with baseline concentrations (13 ) . In addition, hs-CRP concentrations measured immediately and 48 h after a 7-km hill race did not differ from baseline concentrations (14 ) . These conflicting results might be explained by different time frames and differences in exercise intensities. A study of the time course of hs-CRP concentration after surgical procedures showed a rapid increase starting 6 to 8 hours after the operation, with the highest peak at about 48 h and the concentration returning to baseline between 72 h and 144 h after the surgical intervention (39 ) .
Regarding tea and alcohol intake, no publication has addressed the effects on hs-CRP within 24 h after consumption. We found a slight decrease in hs-CRP in association with tea and alcohol intake; however, whether this result reflects regular consumption or an immediate reaction is difficult to determine. A decrease in hs-CRP concentration after consumption of regular black tea (40 ) and moderate amounts of alcohol (6 ) has been shown.
Conclusion
This study is the first to measure within-patient variation in hs-CRP concentration in a large study population. We confirmed and extended published results on the association of patient characteristics and intake of medications with hs-CRP concentrations in male and female MI survivors. Short-term influences, however, did not seem to impact hs-CRP concentrations. Males, elderly individuals, smokers, and patients with increased HbA1c concentrations had greater intraindividual variation in repeated measurements of hs-CRP. In patients with manifest cardiovascular disease, in particular after MI, several hs-CRP measurements may be necessary to adequately characterize their risk, especially in defined subgroups. Whether this variation also makes these patients more susceptible to adverse environmental variables needs further investigation.
